Terlipressin hits phase III endpoint
admin 16th August 2019 Uncategorised 0CONFIRM is the largest-ever prospective study conducted in patients with hepatorenal syndrome type I.
More: Terlipressin hits phase III endpoint
Source: News
CONFIRM is the largest-ever prospective study conducted in patients with hepatorenal syndrome type I.
More: Terlipressin hits phase III endpoint
Source: News
© 1994 - 2025 B.M. Pharmaceuticals